Biofil Chemicals & Pharmaceuticals Chart
Biofil Chemicals & Pharmaceuticals Share Key Metrics
Volume
9157.00
Market Cap
53.61 CR
LTQ@LTP
13@32.94
ATP
33.42
Var Margin
25.05 %
Circuit Range
26.51-39.75
Delivery %
74.66 %
Value
3.06 L
ASM/GSM
No
Market Lot
1
Summary
Biofil Chemicals & Pharmaceuticals Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
43.25
Sector P/B
2.14
Sec. Div. Yield
79.78
Biofil Chemicals & Pharmaceuticals Resistance and Support
Pivot 33.23
Resistance
First Resistance
33.84
Second Resistance
34.54
Third Resistance
35.15
Support
First Support
32.53
Second Support
31.92
Third Support
31.22
Biofil Chemicals & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-13 | Quarterly Results |
Biofil Chemicals & Pharmaceuticals News
About Biofil Chemicals & Pharmaceuticals AboutThe
NSE : 4136
BSE : 524396
ISIN : INE829A01014
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May 1992. The company was dormant and there was nobusiness activity till the financial year 1992-93. The company has come out with its first public issue in Oct. 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently the Company isengaged in manufacturing of range of formulations in the form of Injectables Eye Drops Dry Syrups/ Powders Capsules etc. The company has been in successful operation for the last two years.
Biofil Chemicals & Pharmaceuticals Management
| Name | Position |
|---|---|
| Apoorv Jain | Company Secretary & Compliance Officer |
| Ketan Shah | Chairman & Managing Director |
Biofil Chemicals & Pharmaceuticals Similar Stocks
Biofil Chemicals & Pharmaceuticals FAQs
